Endosense, a Swiss medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, announced...
Genesis Invest AG announced its decision to apply for admittance to the Entry Standard, the Deutsche Bƶrse segment within the Open Market that provides...
